Navigation Links
Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response

mpany.

Contact

Abraxis BioScience, Inc.
Investors and Media:
Christine Cassiano, 310-405-7417
Media:
Claire Campbell, 908-393-8238


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycins Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
2. Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation

Post Your Comments:
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Pipette..., http://www.reportlinker.com/p0164373/Pipett...tm_source=prnewswire&utm_medium=pr&utm_cam...e treated as an integral part of any research labo...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,, ...rch report is available in its catalogue. ,, G..., http://www.reportlinker.com/p0164741/Global-Ma...ce=prnewswire&utm_medium=pr&utm_campaign=p...opsy devices includes the spring loaded core needl...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Medical..., http://www.reportlinker.com/p0164242/Medical-A...m_source=prnewswire&utm_medium=pr&utm_camp...es and sealants is gaining preeminence in medical ...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 1Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
...SAN FRANCISCO, Dec. 17 Medivation, Inc.,(Nasdaq: ...ient enrollment in a,Phase 1-2 dose-escalation cli...r antagonist, in castration-resistant prostate can...the U.S. Food and Drug Administration (FDA) to,adv... The open-label, U.S. Phase 1-2 study evaluated pr...
...EMERYVILLE, Calif., Dec. 17 Neurobiological,Techn...ounced that an independent,Data Safety Monitoring ...cal,trials of Viprinex(TM) for the treatment of ac...As a result, the company has terminated further en...e the data before evaluating the,potential for any...
Other Medicine Technology:Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USNe...wing statement after the Senate voted to begin ful...,, (Logo: http://www.newscom.com/cgi-bin/prnh/... another historic step on the road to enacting hea...dural hurdle, senators will now have an opportunit...
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USN...1990s to eliminate onchocerciasis (river blindness...evalence of the disease in recent years, as eviden... requiring mass drug administration in six endemic...th annual meeting of the American Society of Tropi...
(Date:11/21/2009)... , NH based medical crede... first in its industry to form a partnerhsip with ...he U.S. This partnership will help to transform q... (Vocus) November 21, 2009 -- IS... has announced a new agreement with Amerinet Inc.,...
(Date:11/21/2009)... , Eric J. Hall, presiden...oundation of America (AFA) issued the following st...rment detection as part of the new annual wellness...rotection and Affordable Care Act" that was i...ew York, NY (PRWEB) November 21, 2009 -- Eric J. H...
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...obstructive sleep apnea, a sleep disorder that cau...s a night and appears to also promote bed-wetting ...sociate professor of pediatrics at the University ...lems at night, 66 children (41 percent) were also ...
...nstant stress can make people sick, and now a team...ocused on 119 men and women who were taking care o...ers was compared with that of 106 people of simila...blood of the stressed caregivers compared with blo...
...ive findings in a new study that looked at the rol... medical errors involving medications. The inves...e in medical rounds with doctors resulted in t...in the hospital, an area where previous studies ha...
...appears to prevent or delay the onset of prostate ...he growth of high-grade cancers. More than 18,...teride 5 mg/day or placebo. At baseline, digital r... the finasteride group treated for 7 years, prosta...
...rbilt University shows cholesterol-lowering effect...tea. The study is the first placebo-controlled cli...operties of tea in humans. Studies of large po...nship between tea and lower levels of cholesterol ...
...the ongoing Nurses Health Study II suggest women w...ach day may decrease their risk of developing type...intake has produced conflicting results, with most...a positive effect //because alcohol increases insu...
Other Medicine News:Health News:Sleep Apnea Linked to Bed-Wetting in Kids 2
...g; 96 and E-Gel® 48 gels run in the specially ...h combine the base and power supply in one device.... mother E-Base™ and to other daughter E-Base...esis of two or more E-Gel® 96 or E-Gel® 48...
...lder™ Platform is designed with a spring-loa... E-Gel® 48 gel cassettes stay firmly in place ...lacement and loading from one gel to the next with...g software. In addition, the E-Holder™ Platf...
...units can be used for: Analytical Protein and Pept...g SDS-PAGE gels IEF in ultrathin PAGE gels (Z64,07... Peptide Separation: Non-denaturating PAGE gels an...071-9& Z64,075-1) Molecular Biology: DNA/RNA fragm...
...set up and safe to use, the Gel XL Ultra includes ...garose gels. The unit is compact, requiring a mini...r supply eliminates a tangled mess of leads and co...ety and convenience, the power supply can detect w...
Medicine Products: